Literature DB >> 3258811

Measurement of degraded fecal hemoglobin-heme to estimate gastrointestinal site of occult bleeding. Appraisal of its clinical utility.

M Goldschmiedt1, D A Ahlquist, H S Wieand, D B McGill, W F Taylor, R D Ellefson.   

Abstract

Hemoglobin-heme is variably converted to porphyrin during enterocolic transit. This intestinal converted fraction, as measured by HemoQuant, was elevated as a predictor of the occult bleeding site in 152 patients with discrete lesions. The intestinal converted fraction, expressed as the percentage of total fecal hemoglobin, was similar with upper gastrointestinal and proximal colon lesions. Within the colon, values trended downward with more distal location: means +/- standard deviations were 18 +/- 14 proximal colon, 16 +/- 15 sigmoid, and 10 +/- 10 rectum. The amount of fecal blood also affected the intestinal converted fraction; correcting for hemoglobin concentration improved separation by site. Corrected intestinal converted fraction values were significantly lower with rectal (P less than 0.0005) and sigmoid (P less than 0.02) lesions than with proximal colon lesions. Unfortunately, large within-site variation caused considerable overlap between sites. We conclude that the intestinal converted fraction is influenced by the site and amount of bleeding. However, its clinical utility is compromised by substantial individual differences in luminal hemoglobin metabolism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258811     DOI: 10.1007/bf01798364

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  7 in total

1.  Colonic transit scintigraphy. A physiologic approach to the quantitative measurement of colonic transit in humans.

Authors:  B Krevsky; L S Malmud; F D'Ercole; A H Maurer; R S Fisher
Journal:  Gastroenterology       Date:  1986-11       Impact factor: 22.682

2.  Fecal blood levels in health and disease. A study using HemoQuant.

Authors:  D A Ahlquist; D B McGill; S Schwartz; W F Taylor; R A Owen
Journal:  N Engl J Med       Date:  1985-05-30       Impact factor: 91.245

3.  HemoQuant, a new quantitative assay for fecal hemoglobin. Comparison with Hemoccult.

Authors:  D A Ahlquist; D B McGill; S Schwartz; W F Taylor; M Ellefson; R A Owen
Journal:  Ann Intern Med       Date:  1984-09       Impact factor: 25.391

4.  Fecal blood loss in patients with colonic polyps: a comparison of measurements with 51chromium-labeled erythrocytes and with the Haemoccult test.

Authors:  P Herzog; K H Holtermüller; J Preiss; J Fischer; K Ewe; H J Schreiber; M Berres
Journal:  Gastroenterology       Date:  1982-11       Impact factor: 22.682

5.  The "HemoQuant" test: a specific and quantitative determination of heme (hemoglobin) in feces and other materials.

Authors:  S Schwartz; J Dahl; M Ellefson; D Ahlquist
Journal:  Clin Chem       Date:  1983-12       Impact factor: 8.327

6.  Quantitative fecal recovery of ingested hemoglobin-heme in blood: comparisons by HemoQuant assay with ingested meat and fish.

Authors:  S Schwartz; M Ellefson
Journal:  Gastroenterology       Date:  1985-07       Impact factor: 22.682

7.  Appearance, properties, and origin of altered human hemoglobin in feces.

Authors:  R M Burton; K S Landreth; G H Barrows; D D Jarrett; C L Songster
Journal:  Lab Invest       Date:  1976-08       Impact factor: 5.662

  7 in total
  6 in total

1.  An objective measure of stool color for differentiating upper from lower gastrointestinal bleeding.

Authors:  G R Zuckerman; D R Trellis; T M Sherman; R E Clouse
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

2.  Gastrointestinal blood loss after non-steroidal anti-inflammatory drugs. Measurement by selective determination of faecal porphyrins.

Authors:  A Cohen; J K Boeijinga; P M van Haard; R C Schoemaker; A van Vliet-Verbeek
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

Review 3.  Screening for colorectal cancer by immunochemical fecal occult blood testing.

Authors:  H Saito
Journal:  Jpn J Cancer Res       Date:  1996-10

4.  Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location.

Authors:  L Guittet; V Bouvier; N Mariotte; J P Vallee; R Levillain; J Tichet; G Launoy
Journal:  Br J Cancer       Date:  2009-03-31       Impact factor: 7.640

5.  Evaluation of the guaiac fecal occult blood test for detection of gastrointestinal bleeding in the rhesus macaque (Macaca mulatta).

Authors:  Rachel Elizabeth Cooper; Eric Kenneth Hutchinson; Jessica Marie Izzi
Journal:  J Med Primatol       Date:  2019-11-01       Impact factor: 0.667

6.  Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers.

Authors:  Han-Mo Chiu; Grace Hsiao-Hsuan Jen; Ying-Wei Wang; Jean Ching-Yuan Fann; Chen-Yang Hsu; Ya-Chung Jeng; Amy Ming-Fang Yen; Sherry Yueh-Hsia Chiu; Sam Li-Sheng Chen; Wen-Feng Hsu; Yi-Chia Lee; Ming-Shiang Wu; Chien-Yuan Wu; Yann-Yuh Jou; Tony Hsiu-Hsi Chen
Journal:  Gut       Date:  2021-01-25       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.